Skip to content
Biodatica
Start free

Investigator

Hari Bhaskaran

CISTERNA BIOLOGICS, INC. · funded by NCATS, NIGMS

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$700k

Summed across those awards.

First award
Jun 5, 2025

Latest Aug 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    A Novel Approach to Eliminate Length Impurities for High-Quality mRNA Production

    $350k

    Aug 1, 2025NCATSCISTERNA BIOLOGICS, INC.NIH RePORTER · 11068965 (opens the source filing in a new tab)

  2. R41

    Rapid and Ultra-Pure mRNA Production with Next-Generation RNA Polymerases

    $350k

    Jun 5, 2025NIGMSCISTERNA BIOLOGICS, INC.NIH RePORTER · 11184941 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources